EVKEEZA (evinacumab for injection) is used to treat adults and children aged 5 years and older with very high cholesterol caused by a condition called homozygous familial hypercholesterolemia (HoFH). EVKEEZA is used with a low-fat diet and other medicines to bring down cholesterol levels.
EVKEEZA at a glance:
- Is used to treat HoFH in adults and children 5 and older in combination with other lipid-lowering therapies and a low-fat diet
- Reduces the level of LDL-cholesterol in the blood
- Is a 60-minute IV infusion, given every 4 weeks
What is HoFH?
- People with HoFH have extremely high levels of LDL-cholesterol – or ‘bad cholesterol’ – from birth.
- Cholesterol levels this high can lead to heart attacks, heart valve disease, or other problems at an early age.
- HoFH runs in families and it is usually passed down by both father and mother.
How does EVKEEZA work?
HoFH is a serious disease that is inherited from one's parents that limits the body’s ability to remove bad cholesterol (LDL-C), which causes extremely high levels of bad cholesterol to remain in the body.
With HoFH, ANGPTL3 (a protein) stops the body from removing bad cholesterol. EVKEEZA was developed to block the effects of ANGPTL3.
Evinacumab, the active substance in EVKEEZA, attaches to ANGPTL3 and blocks its effects. When evinacumab blocks the effects of ANGPTL3, the level of LDL-cholesterol in the blood is reduced and problems caused by high LDL-cholesterol levels may also be reduced.
Learn more about EVKEEZA